Matches in Wikidata for { <http://www.wikidata.org/entity/Q64151022> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q64151022 description "clinical trial" @default.
- Q64151022 description "ensayu clínicu" @default.
- Q64151022 description "klinisch onderzoek" @default.
- Q64151022 description "клінічне випробування" @default.
- Q64151022 name "A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia" @default.
- Q64151022 type Item @default.
- Q64151022 label "A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia" @default.
- Q64151022 prefLabel "A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia" @default.
- Q64151022 P1050 Q64151022-7D9207C0-09CA-4DDC-B46C-A82BE3501D73 @default.
- Q64151022 P1132 Q64151022-15F4DA04-AE01-453D-BCC0-9FFFA38A6168 @default.
- Q64151022 P131 Q64151022-D3574EE2-77DA-4F71-BD69-83704028B7EE @default.
- Q64151022 P1476 Q64151022-313F5718-3A06-47A1-A23D-33C3D28B065C @default.
- Q64151022 P17 Q64151022-28002FD3-E536-422A-9EAF-17943B1DA76E @default.
- Q64151022 P17 Q64151022-2B3F3C3B-300D-42B1-B8CE-85E458D99117 @default.
- Q64151022 P17 Q64151022-2D53C3BE-111A-473A-A46A-DDDCA3663001 @default.
- Q64151022 P17 Q64151022-439FAE4A-F266-46E6-A1D3-CD12048E4A67 @default.
- Q64151022 P3098 Q64151022-1D1BFEB2-2172-4F3C-B026-F38C55997FE7 @default.
- Q64151022 P31 Q64151022-147A80F1-38D3-465C-9F00-F3650DAC6E39 @default.
- Q64151022 P4135 Q64151022-3FFEC86D-D7C3-4E6A-9047-1273FE34E9E0 @default.
- Q64151022 P580 Q64151022-C81C736F-1DA2-4616-B5E0-7CE5155E74DC @default.
- Q64151022 P582 Q64151022-22B91B5C-911C-4D65-B33C-B5F03379C7F3 @default.
- Q64151022 P6099 Q64151022-D6B375A9-7E60-4F2C-8C8E-4AC41AE5D3F9 @default.
- Q64151022 P6153 Q64151022-ABB32651-F4AA-4A62-B87F-FB03D1C9220C @default.
- Q64151022 P8363 Q64151022-BB38DB32-0C0D-4332-9855-9DE3C5832B01 @default.
- Q64151022 P859 Q64151022-BF7F5E45-6032-420D-A624-336CBE1798B9 @default.
- Q64151022 P1050 Q5445 @default.
- Q64151022 P1132 "+60" @default.
- Q64151022 P131 Q8646 @default.
- Q64151022 P1476 "A Phase II, Open-label, Non-controlled, Intra-patient Dose-escalation Study to Characterize the Pharmacokinetics After Oral Administration of Eltrombopag in Pediatric Patients With Refractory, Relapsed or Treatment Naive Severe Aplastic Anemia or Recurrent Aplastic Anemia" @default.
- Q64151022 P17 Q145 @default.
- Q64151022 P17 Q30 @default.
- Q64151022 P17 Q45 @default.
- Q64151022 P17 Q55 @default.
- Q64151022 P3098 "NCT03025698" @default.
- Q64151022 P31 Q30612 @default.
- Q64151022 P4135 "+18" @default.
- Q64151022 P580 "2017-05-11T00:00:00Z" @default.
- Q64151022 P582 "2021-08-03T00:00:00Z" @default.
- Q64151022 P6099 Q42824440 @default.
- Q64151022 P6153 Q507154 @default.
- Q64151022 P8363 Q78089383 @default.
- Q64151022 P859 Q507154 @default.